Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion

Journal of Nutritional Biochemistry

Volumn 22, Issue 10, 2011, Pages 910-920

  Kim, Choon Young ^a   Le, Thuc T ^b   Chen, Chihyu ^a   Cheng, Ji Xin ^a,b   Kim, Kee Hong ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

3T3 L1; Adipogenesis; Coherent Anti Stokes Raman Scattering microscope; Curcumin; Mitotic clonal expansion

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CURCUMIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; FAT DROPLET; KRUPPEL LIKE FACTOR 5; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL VIABILITY; COHERENT ANTISTROKES RAMAN SCATTERING MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTRACELLULAR SPACE; LIPID STORAGE; MICROSCOPY; MITOSIS; MOUSE; NONHUMAN; PROADIPOCYTE; QUANTITATIVE ANALYSIS;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MITOSIS; PPAR GAMMA; RNA, MESSENGER; THIAZOLIDINEDIONES;

CURCUMA LONGA; MURINAE;

EID: 80053104570     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.003     Document Type: Article

References (47)

1. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
2. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., et al. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
3. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol Rev 1998, 78:783-809.
4. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
5. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-7.
6. Corson T.W., Crews C.M. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007, 130:769-774.
7. Singh S. From exotic spice to modern drug?. Cell 2007, 130:765-768.
8. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
9. Feng B., Chen S., Chiu J., George B., Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab 2008, 294:E1119-E1126.
10. Li H.L., Liu C., de Couto G., Ouzounian M., Sun M., Wang A.B., et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008, 118:879-893.
11. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A., et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008, 118:868-878.
12. Wongcharoen W., Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 2009, 133:145-151.
13. Seo K.I., Choi M.S., Jung U.J., Kim H.J., Yeo J., Jeon S.M., et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res 2008, 52:995-1004.
14. Weisberg S.P., Leibel R., Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149:3549-3558.
15. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 2009, 139:919-925.
16. Kim K.H., Lee K., Moon Y.S., Sul H.S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001, 276:11252-11256.
17. Zhu J., Lee B., Buhman K.K., Cheng J.X. A dynamic, cytoplasmic triacylglycerol pool in enterocytes revealed by ex vivo and in vivo coherent anti-Stokes Raman scattering imaging. J Lipid Res 2009, 50:1080-1089.
18. Le T.T., Cheng J.X. Single-cell profiling reveals the origin of phenotypic variability in adipogenesis. PLoS ONE 2009, 4:e5189.
19. Wang H.W., Le T.T., Cheng J.X. Label-free imaging of arterial cells and extracellular matrix using a multimodal CARS microscope. Opt Commun 2008, 281:1813-1822.
20. Fu Y., Huff T.B., Wang H.W., Wang H., Cheng J.X. Ex vivo and in vivo imaging of myelin fibers in mouse brain by coherent anti-Stokes Raman scattering microscopy. Opt Express 2008, 16:19396-19409.
21. Nan X., Cheng J.X., Xie X.S. Vibrational imaging of lipid droplets in live fibroblast cells with coherent anti-Stokes Raman scattering microscopy. J Lipid Res 2003, 44:2202-2208.
22. Evans C.L., Xie X.S. Coherent anti-stokes Raman scattering microscopy: chemical imaging for biology and medicine. Annual Review of Analytical Chemistry 2008, 1:883-909.
23. Wang H.W., Fu Y., Huff T.B., Le T.T., Wang H., Cheng J.X. Chasing lipids in health and diseases by coherent anti-Strokes Raman scattering microscopy. Vibrational Spectroscopy 2009, 50:160-167.
24. Mendonca L.M., Dos Santos G.C., Antonucci G.A., Dos Santos A.C., Bianchi Mde L., Antunes L.M. Evaluation of the cytotoxicity and genotoxicity of curcumin in PC12 cells. Mutat Res 2009, 675:29-34.
25. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23:363-398.
26. Menon L.G., Kuttan R., Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 1995, 95:221-225.
27. Tang Q.Q., Lane M.D. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev 1999, 13:2231-2241.
28. Li X., Kim J.W., Gronborg M., Urlaub H., Lane M.D., Tang Q.Q. Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation. Proc Natl Acad Sci U S A 2007, 104:11597-11602.
29. Tang Q.Q., Gronborg M., Huang H., Kim J.W., Otto T.C., Pandey A., et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci U S A 2005, 102:9766-9771.
30. Tang Q.Q., Otto T.C., Lane M.D. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 2003, 100:850-855.
31. Cho Y.C., Jefcoate C.R. PPARgamma1 synthesis and adipogenesis in C3H10T1/2 cells depends on S-phase progression, but does not require mitotic clonal expansion. J Cell Biochem 2004, 91:336-353.
32. Iwata M., Haruta T., Usui I., Takata Y., Takano A., Uno T., et al. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-gamma. Diabetes 2001, 50:1083-1092.
33. Johnson J.J., Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett 2007, 255:170-181.
34. Shishodia S., Amin H.M., Lai R., Aggarwal B.B. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005, 70:700-713.
35. Kim S.J., Hellerstein M.K. Pharmacological doses of dietary curcumin increase colon epithelial cell proliferation in vivo in rats. Phytother Res 2007, 21:995-998.
36. Kim S.J., Son T.G., Park H.R., Park M., Kim M.S., Kim H.S., et al. Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 2008, 283:14497-14505.
37. Tang Q.Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A 2003, 100:44-49.
38. Park B.H., Qiang L., Farmer S.R. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 2004, 24:8671-8680.
39. Oishi Y., Manabe I., Tobe K., Tsushima K., Shindo T., Fujiu K., et al. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 2005, 1:27-39.
40. Ahn J., Lee H., Kim S., Ha T. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am J Physiol Cell Physiol 2010, 298:C1510-1516.
41. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953.
42. Kim S.I., Park C.S., Lee M.S., Kwon M.S., Jho E.H., Song W.K. Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin. Biochem Biophys Res Commun 2004, 317:478-483.
43. Park C.S., Kim S.I., Lee M.S., Youn C.Y., Kim D.J., Jho E.H., et al. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2. J Biol Chem 2004, 279:19592-19599.
44. Lee Y.K., Lee W.S., Hwang J.T., Kwon D.Y., Surh Y.J., Park O.J. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J Agric Food Chem 2009, 57:305-310.
45. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998, 64:353-356.
46. Ravindranath V., Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology 1980, 16:259-265.
47. Pan M.H., Huang T.M., Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999, 27:486-494.